These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18479470)

  • 1. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication overuse headache: findings from cerebrospinal fluid.
    Holland PR; Bartsch T
    Cephalalgia; 2008 Jul; 28(7):681-2. PubMed ID: 18479470
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.
    Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P
    Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine function is altered in chronic migraine patients with medication-overuse.
    Rainero I; Ferrero M; Rubino E; Valfrè W; Pellegrino M; Arvat E; Giordano R; Ghigo E; Limone P; Pinessi L
    Headache; 2006 Apr; 46(4):597-603. PubMed ID: 16643554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
    Brundin L; Björkqvist M; Petersén A; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2007 Sep; 17(9):573-9. PubMed ID: 17346943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stress and migraine interaction.
    Sauro KM; Becker WJ
    Headache; 2009 Oct; 49(9):1378-86. PubMed ID: 19619238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic skin response in migraineurs and patients with medication overuse headache.
    Atasoy HT; Atasoy N; Unal AE; Sumer M
    Headache; 2004 Apr; 44(4):305-10. PubMed ID: 15109353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional-MRI evaluation of pain processing in chronic migraine with medication overuse.
    Chiapparini L; Grazzi L; Ferraro S; Mandelli ML; Usai S; Andrasik F; Bruzzone MG; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S71-4. PubMed ID: 19415430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Laughing Matter: Gelastic Migraine and Other Unusual Headache Syndromes.
    Mathew PG; Robertson CE
    Curr Pain Headache Rep; 2016 May; 20(5):32. PubMed ID: 27038971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability in chronic migraine with medication overuse: treatment effects at 3 years.
    Andrasik F; Grazzi L; Usai S; D'Amico D; Kass S; Bussone G
    Headache; 2007 Oct; 47(9):1277-81. PubMed ID: 17927643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From migraine to chronic daily headache: the biological basis of headache transformation.
    Meng ID; Cao L
    Headache; 2007 Sep; 47(8):1251-8. PubMed ID: 17883547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessons.
    Bigal ME; Lipton RB
    Headache; 2006 Oct; 46 Suppl 3():S144-6. PubMed ID: 17034393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretins and primary headaches: neurobiology and clinical implications.
    Rainero I; De Martino P; Pinessi L
    Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache.
    Cady RK; Schreiber CP; Farmer KU
    Headache; 2004 May; 44(5):426-35. PubMed ID: 15147250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of salience network intranetwork resting state functional connectivity in women with chronic migraine.
    Androulakis XM; Rorden C; Peterlin BL; Krebs K
    Cephalalgia; 2018 Oct; 38(11):1731-1741. PubMed ID: 29237282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of medication-overuse headache.
    Obermann M; Katsarava Z
    Expert Rev Neurother; 2007 Sep; 7(9):1145-55. PubMed ID: 17868013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it?
    Raggi A; Grazzi L; Grignani E; Leonardi M; Sansone E; Scaratti C; D'Amico D
    Neurol Sci; 2018 Jun; 39(Suppl 1):125-127. PubMed ID: 29904852
    [No Abstract]   [Full Text] [Related]  

  • 17. Degradation of endocannabinoids in chronic migraine and medication overuse headache.
    Cupini LM; Costa C; Sarchielli P; Bari M; Battista N; Eusebi P; Calabresi P; Maccarrone M
    Neurobiol Dis; 2008 May; 30(2):186-9. PubMed ID: 18358734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication overuse in Moldova. Chronic migraine with and without medication overuse: the role of drug phobia and associated factors (according to the data of Headache Centre, Chisinau, the Republic of Moldova).
    Moldovanu I; Odobescu S; Craciun C
    Cephalalgia; 2008 Nov; 28(11):1229-33. PubMed ID: 18983593
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients.
    Ferrari A; Savino G; Gallesi D; Pinetti D; Bertolini A; Sances G; Coccia CP; Pasciullo G; Leone S; Loi M; Sternieri E
    Pharmacol Res; 2006 Aug; 54(2):142-9. PubMed ID: 16697657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.